Type 1 diabetes and C-reactive protein increased

Summary:

C-reactive protein increased is found among people with Type 1 diabetes, especially for people who are female, 30-39 old.

The study analyzes which people have C-reactive protein increased with Type 1 diabetes. It is created by eHealthMe based on reports of 32 people who have Type 1 diabetes from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Type 1 diabetes?

Type 1 diabetes is found to be associated with 668 drugs and 1,644 conditions by eHealthMe. Check the latest studies of Type 1 diabetes.

What is C-reactive protein increased?

C-reactive protein increased is found to be associated with 1,569 drugs and 2,281 conditions by eHealthMe. Check the latest studies of C-reactive protein increased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 17, 2026

32 people who have Type 1 Diabetes and C-Reactive Protein Increased are studied.

Would you have C-reactive protein increased when you have Type 1 diabetes?

Gender of people who have Type 1 Diabetes and experienced C-Reactive Protein Increased *:

  • female: 68.75 %
  • male: 31.25 %

Age of people who have Type 1 Diabetes and experienced C-Reactive Protein Increased *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 8 %
  • 20-29: 12 %
  • 30-39: 32 %
  • 40-49: 12 %
  • 50-59: 20 %
  • 60+: 16 %

Common co-existing conditions for these people *:

  1. Urticaria (rash of round, red welts on the skin that itch intensely): 5 people, 15.62%
  2. Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 5 people, 15.62%
  3. Asthma: 5 people, 15.62%
  4. Chronic Thyroiditis (long lasting inflammation of thyroid gland): 5 people, 15.62%
  5. Hepatitis B: 5 people, 15.62%
  6. Transplant Rejection (a transplant material is not worked): 5 people, 15.62%
  7. High Blood Pressure: 3 people, 9.38%
  8. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 9.38%
  9. High Blood Cholesterol: 2 people, 6.25%
  10. Pain: 1 person, 3.12%

Common drugs taken by these people *:

  1. Novorapid: 11 people, 34.38%
  2. Insulin: 8 people, 25.00%
  3. Humalog: 8 people, 25.00%
  4. Lantus: 7 people, 21.88%
  5. Emtricitabine: 5 people, 15.62%
  6. Xolair: 5 people, 15.62%
  7. Symbicort: 5 people, 15.62%
  8. Propofol: 5 people, 15.62%
  9. Naproxen: 5 people, 15.62%
  10. Prednisolone: 5 people, 15.62%

Common symptoms for these people *:

  1. Leukocytosis (increased white blood cells): 12 people, 37.50%
  2. Nausea And Vomiting: 9 people, 28.12%
  3. Fatigue (feeling of tiredness): 8 people, 25.00%
  4. Fever: 7 people, 21.88%
  5. Nausea (feeling of having an urge to vomit): 7 people, 21.88%
  6. Blood Glucose Abnormal: 7 people, 21.88%
  7. Blood Lactate Dehydrogenase Increased: 6 people, 18.75%
  8. Platelet Count Increased: 6 people, 18.75%
  9. Neisseria Infection (a bacterial infection): 5 people, 15.62%
  10. Diabetic Ketoacidosis (diabetic ketoacidosis (dka) is high concentrations of ketone bodies): 5 people, 15.62%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have C-reactive protein increased?

- Check whether C-reactive protein increased is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with C-reactive protein increased:

All the conditions that are associated with C-reactive protein increased:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on C-reactive protein increased and Type 1 diabetes, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: